Chu Shelley

SEC Form 4 insider trading activity

Chu Shelley has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 12, 2026.

On the most recent filing, Chu Shelley is listed as Director at Odyssey Therapeutics, Inc. Inside the rolling window, Chu Shelley reported 1 open-market purchase totaling $200K in ODTX and no open-market sales.

Companies traded

Other insiders at ODTX

Insider Buying

$200K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ODTX
Chu Shelley
Purchase$200KMay 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Chu Shelley made?

Chu Shelley has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Chu Shelley trade?

Chu Shelley has filed SEC Form 4 disclosures for 1 company, including ODTX.

When was Chu Shelley's most recent SEC Form 4 filing?

Chu Shelley's most recent SEC Form 4 filing on Tracefour is dated May 12, 2026.

What is Chu Shelley's total buy and sell value in the current window?

Inside the rolling retention window, Chu Shelley bought $200K and sold $0 based on SEC Form 4 filings.

What was Chu Shelley's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 11,111 ODTX shares on 2026-05-11, worth $200K, per SEC Form 4 filings.